Mark Altmeyer
Director/Board Member at ALECTOR, INC.
Net worth: - $ as of 2024-04-29
Profile
Mark F.
Altmeyer is the founder of Arvelle Therapeutics International GmbH (founded in 2019) and holds the title of Chief Executive Officer & Director.
He is also the founder of Arvelle Therapeutics BV.
Mr. Altmeyer's current job positions include Chairman-Supervisory Board at AM-Pharma BV (since 2021), Executive Director at Novaremed AG (since 2021), Director at Contact of Mercer County, Independent Director at Clarion Healthcare LLC, and Director at Alector, Inc. (starting in 2024).
Mr. Altmeyer's former job positions include President & Chief Executive Officer at Otsuka America Pharmaceutical, Inc. (2009-2014), Director at Roivant Sciences GmbH, Independent Director at Myovant Sciences Ltd.
(2016-2018), Senior Vice President at Bristol Myers Squibb Co. (2006-2008), President & Chief Commercial Officer at Sio Gene Therapies, Inc. (2015-2019), President & Chief Commercial Officer at Axovant Sciences, Inc. (2016), and President & Chief Commercial Officer at Axovant Sciences GmbH (2016-2019).
Mr. Altmeyer's education includes an undergraduate degree from Middlebury College and an MBA from Harvard Business School.
Mr. Altmeyer is also the founder of Arvelle Therapeutics BV.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALECTOR, INC.
-.--% | 2024-03-30 | 0 ( -.--% ) | - $ | 2024-04-29 |
Mark Altmeyer active positions
| Companies | Position | Start |
|---|---|---|
| ALECTOR, INC. | Director/Board Member | 2024-03-18 |
Contact of Mercer County
 Contact of Mercer County Miscellaneous Commercial ServicesCommercial Services Contact of Mercer County provides compassionate and confidential telephone listening and referral services. The non-profit company is based in Pennington, NJ. | Director/Board Member | - |
Arvelle Therapeutics International GmbH
 Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Founder | 2018-12-31 |
Arvelle Therapeutics BV
 Arvelle Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Arvelle Therapeutics BV is a Dutch biopharmaceutical company that focuses on providing innovative solutions to patients with CNS disorders. The private company is responsible for developing and commercializing an investigational anti-seizure medicine called Cenobamate in the European market. Arvelle received start-up financing of $207.80 million, which is one of the largest initial financing commitments for a European-focused biopharmaceutical company. The company is headquartered in Amsterdam, Netherlands. Arvelle was founded by Gregory Mark Weinhoff and Mark F. Altmeyer, and Mark F. Altmeyer has been the CEO since incorporation. | Founder | - |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Chairman | 2021-07-05 |
Novaremed AG
 Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Director/Board Member | 2021-11-30 |
Clarion Healthcare LLC
 Clarion Healthcare LLC Miscellaneous Commercial ServicesCommercial Services Clarion Healthcare LLC engages in healthcare industry. The firm offers strategies and organizational consultancy services. The company is was founded by Thomas Murtagh and Bart Lombardi and is headquartered in Boston, MA. | Independent Dir/Board Member | - |
Former positions of Mark Altmeyer
| Companies | Position | End |
|---|---|---|
| SIO GENE THERAPIES INC. | President | 2019-02-14 |
Axovant Sciences GmbH
 Axovant Sciences GmbH Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences GmbH is a Swiss clinical-stage biopharmaceutical company that focuses on the treatment of dementia. The company is based in Basel, Switzerland. | Chief Executive Officer | - |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Mark Altmeyer
| Middlebury College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ALECTOR, INC. | Health Technology |
| Private companies | 12 |
|---|---|
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
Axovant Sciences GmbH
Axovant Sciences GmbH Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences GmbH is a Swiss clinical-stage biopharmaceutical company that focuses on the treatment of dementia. The company is based in Basel, Switzerland. | Health Technology |
Contact of Mercer County
Contact of Mercer County Miscellaneous Commercial ServicesCommercial Services Contact of Mercer County provides compassionate and confidential telephone listening and referral services. The non-profit company is based in Pennington, NJ. | Commercial Services |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Health Technology |
Arvelle Therapeutics BV
Arvelle Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Arvelle Therapeutics BV is a Dutch biopharmaceutical company that focuses on providing innovative solutions to patients with CNS disorders. The private company is responsible for developing and commercializing an investigational anti-seizure medicine called Cenobamate in the European market. Arvelle received start-up financing of $207.80 million, which is one of the largest initial financing commitments for a European-focused biopharmaceutical company. The company is headquartered in Amsterdam, Netherlands. Arvelle was founded by Gregory Mark Weinhoff and Mark F. Altmeyer, and Mark F. Altmeyer has been the CEO since incorporation. | Commercial Services |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Health Technology |
Clarion Healthcare LLC
Clarion Healthcare LLC Miscellaneous Commercial ServicesCommercial Services Clarion Healthcare LLC engages in healthcare industry. The firm offers strategies and organizational consultancy services. The company is was founded by Thomas Murtagh and Bart Lombardi and is headquartered in Boston, MA. | Commercial Services |
- Stock Market
- Insiders
- Mark Altmeyer
